Highly Improved Metabolic Stability and Pharmacokinetics of Indium-111-DOTA-Gastrin Conjugates for Targeting of the Gastrin Receptor-Reference-Cited by-同舟云学术

Highly Improved Metabolic Stability and Pharmacokinetics of Indium-111-DOTA-Gastrin Conjugates for Targeting of the Gastrin Receptor

Published:2011-04-01 Issue:8 Volume:54 Page:2602-2609
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Kolenc-Peitl Petra¹,Mansi Rosalba²³,Tamma MariaLuisa²,Gmeiner-Stopar Tanja¹,Sollner-Dolenc Marija⁴,Waser Beatrice⁵,Baum Richard P.⁶,Reubi Jean Claude⁵,Maecke Helmut R.²³

Affiliation:

1. Department of Nuclear Medicine, University Medical Centre Ljubljana, Zaloška Cesta 7, SI-1000 Ljubljana, Slovenia

2. Division of Radiological Chemistry, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland

3. Department of Nuclear Medicine, University of Freiburg, Hugstetterstrasse 55, 79106 Freiburg, Germany

4. Faculty of Pharmacy, University of Ljubljana, Aškerčeva Cesta 7, SI-1000 Ljubljana, Slovenia

5. Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Berne, Murtenstrasse 31, CH-3010 Berne, Switzerland

6. Department of Nuclear Medicine/PET Center, Zentralklinik Bad Berka, Bad Berka, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm101279a

Reference23 articles.

1. Cholecystokinin and Gastrin Receptors

2. Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma

3. Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma

4. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significant reduction of activity retention in the kidneys via optimized linker sequences in radiohybrid-based minigastrin analogs;EJNMMI Research;2024-03-02

2. Precision peptide theranostics: developing N- to C-terminus optimized theranostics targeting cholecystokinin-2 receptor;Theranostics;2024

3. Development of Highly Potent Clinical Candidates for Theranostic Applications against Cholecystokinin-2 Receptor Positive Cancers;Journal of Medicinal Chemistry;2023-07-26

4. Effect of N-Terminal Peptide Modifications on In Vitro and In Vivo Properties of 177Lu-Labeled Peptide Analogs Targeting CCK2R;Pharmaceutics;2023-02-28

5. Development and biodistribution studies of 77As-labeled trithiol RM2 bioconjugates for prostate cancer: Comparison of [77As]As-trithiol-Ser-Ser-RM2 vs. [77As]As-trithiol-Glu-Ser-RM2;Nuclear Medicine and Biology;2022-05